F/M Emerald Life Sciences Innovation ETF (LFSC) Dividend Yield, History & Forecast

F/M Emerald Life Sciences Innovation ETF (LFSC) is an exchange-traded fund (ETF) listed on the NASDAQ Global Select. market capitalization is approximately $121M.

LFSC fund composition

LFSC holds 41 positions, with 54.1% of assets in its ten largest. It charges an expense ratio of 0.79%, and manages $127.0M.

Top 10 holdings

HoldingWeight
TVTXTravere Therapeutics Inc8.80%
LIVNLivaNova PLC6.80%
CORTCorcept Therapeutics Inc6.52%
SYRESpyre Therapeutics Inc6.50%
COGTCogent Biosciences Inc6.37%
MIRMMirum Pharmaceuticals Inc4.38%
BLLNBilliontoone Inc4.07%
GHGuardant Health Inc3.90%
CYTKCytokinetics Inc3.53%
AXSMAxsome Therapeutics Inc3.21%

Frequently Asked Questions about F/M Emerald Life Sciences Innovation ETF (LFSC)

What does F/M Emerald Life Sciences Innovation ETF invest in?
The F/M Emerald Life Sciences Innovation ETF (LFSC) strategically invests in pioneering life science enterprises. Its core objective is to identify companies that are well-positioned for substantial long-term growth and the creation of significant value. As an actively managed fund, LFSC benefits from a highly specialized and experienced team dedicated to conducting in-depth research into complex life sciences firms. The fund primarily targets U.S. equity securities, selecting those that demonstrate strong growth potential. Specific criteria for inclusion involve a company's leadership in...